Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wow how low does GRAY go???
No news.
No financing.
No Pipeline updates???
GLTA
Yes! Let Gold run!
GLTA
Hope Gold continues UP after this brief pull back...
Stayed above 1840 so....
GLTA
Gold UP. What makes this move???!!!
Understood we’re leveraged but c’mon now!
Gold UP. What makes this move???!!!
Understood we’re leveraged but c’mon now!
$240 should hit today! Maybe AH…
GLTA
$240 and then $260 I said…
GLTA
Congrats! Same here...
GLTA
It was $242 yesterday !!!
Likely back over $250 by Friday, and over $270 next week...
I'm not a big fan personally, but as a business FB sits on a boat load of CASH...
GLTA
Spot on! Like it or not - it's gonna happen !!!
GLTA
Thanks RN. Gray’s ridiculous low volume & watching L2 says algo trading having fun. For what though? Volume says barely making few $$???!!
What was S1 filing just went through??
(I’m driving so TYIA)
Gold 1/25/2022=$1853. Last time Gold hit this JNUG was $90-$100 so HOW did JNUG go down just now???!!!
Great time to BUY?!
*See previous message chart comparison...
GLTA
...
.....
Gold 1/25/2022=$1853. Last time Gold hit this GDXU was $17-$20 so HOW did GDXU go down just now???!!!
Great time to BUY?!
*See previous message chart comparison...
GLTA
...
.....
My adds today were $1.40 also.
1.38 & 1.39 wouldn’t fill…
GLTA
GRAY 1/20/2022: hires 6 new Top-Executives..
This WILL move the needle... Especially with GRAY's crazy LOW-FLOAT !
"Graybug Vision Makes Key Hires to Further Build Momentum Behind its Pipeline. January 20 2022 - 07:30AM. GlobeNewswire Inc.
Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced the hiring of six new employees who will enhance Graybug’s Research & Development (R&D), Regulatory Affairs and Program Management capabilities, as the Company further builds momentum behind its pipeline in 2022.
“We are at a critical stage in our efforts to further progress and diversify our pipeline with new, high-value programs. I strongly believe that strengthening our world-class ophthalmology team is key to our future success. I am therefore pleased to welcome several new team members, who add critical leadership in Regulatory Affairs and Program Management, as well as further deepen our teams’ capabilities in R&D,” said Fred Guerard, Pharm D, CEO of Graybug.
Among Graybug’s key hires are Fang Li, Vice President, Regulatory Affairs, and Ali Kakavand, Vice President, Head of Program Management:
- Fang Li, PhD, RAC, brings over 30 years of drug development and more than 20 years of regulatory affairs experience. She worked across small molecules, biologics, gene therapy, over-the-counter products, in-vitro diagnostic products, and medical devices, with a focus on ophthalmology. She has a proven track record in negotiating and gaining regulatory approvals in the US and other regions. Most recently, Fang was VP, Regulatory Affairs at Hurley Consulting Associated, Ltd where she led the regulatory affairs department providing strategic and operational services to clients in the pharmaceutical and biotech industry. Fang holds a doctoral degree in medicinal chemistry from China Pharmaceutical University, Nanjing, a master’s degree in organic chemistry from Wuhan University, and a bachelor's degree in organic chemistry from Xiamen University, P. R. China.
- Ali Kakavand, PhD, has over 20 years of experience in program and project management for the development of medical devices and pharmaceuticals across multiple therapeutic areas. He has extensive knowledge in the management of global clinical studies, device development, clinical manufacturing, as well as regulatory submissions. Most recently, Ali served as Director of Strategy, Program and Portfolio Management at Alexion (acquired by AstraZeneca) managing a first-of-its-kind marketed drug in hematology, as well as a drug/device combination product in phase 1 clinical development. Ali received his PhD in Biomedical Engineering from Arizona State University, where he completed his dissertation conducting research at The Neurosciences Institute in the field of Biomechanics and Neuromuscular Control.
The compensation committee of Graybug’s board of directors granted the six newly-hired employees inducement options to purchase an aggregate of 234,200 shares of Graybug common stock on January 14, 2022, as inducements material to each employee entering employment with Graybug. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
The options have an exercise price of $1.55 per share, which was equal to the closing price of Graybug common stock on the grant date. One-fourth of the options vest on the one-year anniversary of the vesting commencement date and the remainder vest in equal monthly installments over the next three years, in each case subject to the new employee’s continued service with the company. Each stock option has a 10-year term and is subject to the terms and conditions of a stock option agreement covering the grant."
GLTA
.
.
....
Gold broke the $1830 so lets see 4-6 weeks straight UP !
GLTA
GRAY low-volume take-down continues...
40k trade days make easy back & forth BS...
Let's have some news GRAY
DWAC pushing past $100 seems easy today.
So many above $91 already pre-market !
LOW FLOAT = FAST MOVER with DWAC...
GLTA
....
.....
........
Easy push UP after-hours with DWAC low float!
Let's peg $100 !!!
GLTA
Lets run DWAC UP after-hours !!!
GLTA
DWAC levels off in $120s?
GLTA
Damn SAM. Look out below after hours. “Sam cuts FY21 EPS $2-$6”.
Hope this TRULY disaster turns around. Maybe in Spring…
GLTA
TLSS's 1/13 SEC form D filing listed above in news alerts.
https://www.sec.gov/Archives/edgar/data/0001463208/000146320822000001/xslFormDX01/primary_doc.xml
GLTA
What was the TLSS Sec filing just got notice of today 1/13/2022?
GLTA
Thats 3mo old news NOT current for DWAC....
GLTA
GRAY low volume take down working.
Again.
News on financing & progress please!
GLTA
Thanks & have a great weekend!
ASStute investor obviously..
Thanks for you detailed information.
Again.
GLTA
Like I said - DWAC gift this am...
Continued UP after hours too....
GLTA
SNGX is time...
GLTA
Gold temporary 1% dip = 10% dip for us?
What the heck!
Inflation is unbearable & unstopable at this point...
Gold is the way to go (crypto still too unstable)
GLTA
Gold temporary 1% dip = 10% dip for us?
What the heck!
Inflation is unbearable & unstopable at this point...
Gold is the way to go (crypto still too unstable)
GLTA
Insain was that speach we just saw...
DWAC gift today...
GLTA
GRAY float still only 21mm so should be a non-issue..
Short interest is highest in history..
GLTA
GRAY with new all time lows AGAIN today...
When will GRAY turn
Thanks again for your in depth ANALysis & comments.
GLTA
GRAY day. The sun'l come out tomorrow...
???
GLTA
Thank you for you in depth analysis.
I see you do same on all posts for all pinks…
I bet you are a successful trader